'1038 nrendo' presentation slideshows

Figure 1 Changes in gut microbiota composition and metabolism

Figure 1 Changes in gut microbiota composition and metabolism. Cani, P. D. (2013) The gut microbiota manages host metabolism Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.240.

320 views • 1 slides

302 views • 1 slides

259 views • 1 slides

Figure 1 Structures of selective and nonselective estrogen receptor ligands

Figure 1 Structures of selective and nonselective estrogen receptor ligands. Prossnitz, E. R. & Barton, M. (2011) The G-protein-coupled estrogen receptor GPER in health and disease Nat. Rev. Endocrinol. doi:10.1038/nrendo.2011.122.

155 views • 1 slides

Figure 1 PCSK9 binds the LDL receptor (LDLR), targeting it for degradation

471 views • 1 slides

Figure 5 Relationship between MPRI and LV torsion

Figure 5 Relationship between MPRI and LV torsion. Kuehl, M. & Stevens, M. J. (2012) Cardiovascular autonomic neuropathies as complications of diabetes mellitus Nat. Rev. Endocrinol. doi:10.1038/nrendo.2012.21.

90 views • 1 slides

Figure 3 Structural domains of a typical laminin chain

Figure 3 Structural domains of a typical laminin chain. Cheng, C. Y. & Mruk, D. D. (2010) A local autocrine axis in the testes that regulates spermatogenesis Nat. Rev. Endocrinol. doi:10.1038/nrendo.2010.71.

102 views • 1 slides

219 views • 1 slides

Table 1 Current major indications and contraindications for PMHT

Table 1 Current major indications and contraindications for PMHT. Rozenberg, S. et al. (2013) Postmenopausal hormone therapy: risks and benefits Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.17.

136 views • 1 slides

Table 1 Trials on GH, GHRH analogue or GH secretagogue therapy in obesity

Table 1 Trials on GH, GHRH analogue or GH secretagogue therapy in obesity. Berryman, D. E. et al. (2013) The GH/IGF?1 axis in obesity: pathophysiology and therapeutic considerations Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.64.

103 views • 1 slides

Figure 3 Immune modulation and therapeutic opportunities

Figure 3 Immune modulation and therapeutic opportunities. Roep, B. O. & Tree, T. I. M. (2014) Immune modulation in humans: implications for type 1 diabetes mellitus Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.2.

159 views • 1 slides

Figure 1 Natural history of the immunopathogenesis of T1DM

Figure 1 Natural history of the immunopathogenesis of T1DM. Roep, B. O. & Tree, T. I. M. (2014) Immune modulation in humans: implications for type 1 diabetes mellitus Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.2.

282 views • 1 slides

Figure 3 K ATP channel modulation of ??cell electrical activity

Figure 3 K ATP channel modulation of ??cell electrical activity. Ashcroft, F. M. & Rorsman, P. (2013) K ATP channels and islet hormone secretion: new insights and controversies Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.166.

99 views • 1 slides

nrendo.2010.147-pt4

127 views • 1 slides

116 views • 1 slides

Table 5 Surgical review Corporation * data from 272 ASMBS Centers of Excellence

88 views • 1 slides

Table 3 The effects of RYGB procedures on weight loss and resolution of T2DM

108 views • 1 slides

Figure 1 Two models for PICK1 and ICA69 proteins in mature secretory granules formation

Figure 1 Two models for PICK1 and ICA69 proteins in mature secretory granules formation. Arvan, P. & Castle, D. (2013) Regulated secretory cells go to the BAR for a bud Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.121.

150 views • 1 slides

nrendo.2013.227-pf2

171 views • 1 slides

Figure 2 Main effects of GH replacement therapy in adult GH deficiency

Figure 2 Main effects of GH replacement therapy in adult GH deficiency. Kargi, A. Y. & Merriam, G. R. (2013) Diagnosis and treatment of growth hormone deficiency in adults Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.77.

91 views • 1 slides